Locally released dexamethasone and its effects on osteogenic activity at implant‐tissue interface

Abstract

AbstractThe osseointegration of titanium implants within the host tissue holds crucial importance. The introduction of functional coatings at tissue—implant interface enhances the bioactivity of titanium implants, improves their therapeutic outcomes, and enhances the effectiveness of treatments. In this study, we focused on enhancing the bioactivity of titanium‐based implant materials by coating the titanium surfaces with chitosan microspheres, which are loaded with osseointegration‐promoting agent dexamethasone (DEX). Initially, chitosan microspheres were successfully produced, followed by DEX loading through diffusion, resulting in a drug loading efficiency of around 50.2 (wt %). The subsequent drug release profile displayed a 24‐hour duration, releasing approximately 32.6 (wt %) of the loaded DEX. In cell proliferation assays using human osteosarcoma (SAOS‐2) cells, Ti surfaces coated with DEX‐loaded chitosan microspheres initially exhibited lower cell numbers compared with DEX‐free ones. This observation was attributed to transient osteogenic differentiation effects of DEX, since a notable increase in cell proliferation was observed on the 7th day. Von Kossa staining revealed mineralization beginning on the 14th day, particularly evident in DEX‐loaded samples. Moreover, alkaline phosphatase (ALP) activity displayed a pattern of initial increase and subsequent decrease, with DEX release from chitosan microspheres showing a clear influence on the osteogenic differentiation, especially on the 7th day. These findings align with literature, highlighting DEX's potential to enhance osteogenic differentiation and cellular behavior on chitosan microsphere‐coated titanium surfaces. This study emphasizes the promising implications for functionalizing surfaces of implant materials with DEX‐loaded chitosan microspheres to improve their biocompatibility and bioactivity.